Tech Company Financing Transactions
Ataxion Funding Round
On 3/31/2016, Ataxion raised $17 million in funding from Atlas Accelerator and private investors.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25 1st St. 303
Cambridge, MA 02141
USA
Cambridge, MA 02141
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joshua Resnick
Browse more venture capital transactions:
Prev: 3/31/2016: Valeritas Holdings venture capital transaction
Next: 3/31/2016: Thrive Networks venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs